|
Description:
|
|
Send us a text If our visual scoring is still based on gut feeling, how do we scale precision? In this week’s DigiPath Digest, I explored four new AI-focused papers that could reshape how we diagnose prostate, bladder, gastroesophageal, and endocrine cancers. From automated IHC scoring to predicting urethral recurrence post-cystectomy, these studies highlight the growing value—and responsibility—of integrating AI into our pathology workflows. And yes, I also reveal where to get my histology-inspired earrings |